QuidelOrtho Corp. (QDEL)
12.58
+0.44
(+3.62%)
USD |
NASDAQ |
Oct 06, 16:00
12.58
0.00 (0.00%)
After-Hours: 20:00
QuidelOrtho Free Cash Flow : -211.20M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -211.20M |
| March 31, 2026 | -159.40M |
| December 31, 2025 | -83.00M |
| September 30, 2025 | -153.10M |
| June 30, 2025 | 13.00M |
| March 31, 2025 | -35.90M |
| December 31, 2024 | -112.10M |
| September 30, 2024 | -96.80M |
| June 30, 2024 | -170.10M |
| March 31, 2024 | -118.80M |
| December 31, 2023 | 70.90M |
| September 30, 2023 | 146.80M |
| June 30, 2023 | 108.50M |
| March 31, 2023 | 388.73M |
| December 31, 2022 | 744.40M |
| September 30, 2022 | 925.75M |
| June 30, 2022 | 936.15M |
| March 31, 2022 | 484.55M |
| December 31, 2021 | 513.14M |
| September 30, 2021 | 634.41M |
| June 30, 2021 | 711.94M |
| March 31, 2021 | 1.017B |
| December 31, 2020 | 564.84M |
| September 30, 2020 | 193.00M |
| June 30, 2020 | 151.66M |
| Date | Value |
|---|---|
| March 31, 2020 | 133.92M |
| December 31, 2019 | 106.52M |
| September 30, 2019 | 102.45M |
| June 30, 2019 | 92.90M |
| March 31, 2019 | 101.18M |
| December 31, 2018 | 104.14M |
| September 30, 2018 | 76.22M |
| June 30, 2018 | 67.15M |
| March 31, 2018 | 15.20M |
| December 31, 2017 | 10.20M |
| September 30, 2017 | 16.29M |
| June 30, 2017 | 23.72M |
| March 31, 2017 | 35.37M |
| December 31, 2016 | -0.157M |
| September 30, 2016 | -3.448M |
| June 30, 2016 | -9.378M |
| March 31, 2016 | -22.35M |
| December 31, 2015 | 16.21M |
| September 30, 2015 | 24.64M |
| June 30, 2015 | 33.67M |
| March 31, 2015 | 37.40M |
| December 31, 2014 | 26.60M |
| September 30, 2014 | 6.162M |
| June 30, 2014 | -2.664M |
| March 31, 2014 | -9.424M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| IDEXX Laboratories, Inc. | 1.233B |
| Neogen Corp. | 31.90M |
| Aspira Women's Health, Inc. | -5.113M |
| VolitionRX Ltd. | -18.86M |
| Lucid Diagnostics, Inc. | -47.18M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -110.60M |
| Cash from Investing (Quarterly) | -107.30M |
| Cash from Financing (Quarterly) | 200.60M |
| Free Cash Flow Per Share (Quarterly) | -1.993 |
| Free Cash Flow to Equity (Quarterly) | -336.80M |
| Free Cash Flow to Firm (Quarterly) | -73.86M |
| Free Cash Flow Yield | -24.64% |